TOPIC Trial for COPD

Summary

The study is a randomized, double-blind, placebo-controlled, multiple-dose, pilot study of orally-administered ivacaftor in subjects with chronic obstructive pulmonary disease. Subjects will be administered the study drug ivacaftor 150 mg (or placebo) twice daily (BID).

Timeline

Start

2015-05

Primary completion

2015-10

Completion

2015-11

Drugs

Indications